Sort
64,565 grants matching “drug discovery”
Discovery Pipeline (2 of 4)
$2,074,448Todd R. Golub · Massachusetts Institute Of Technology · RL1 · FY2008 · CA
Disease mechanism and therapies for retinal degeneration
$2,072,913Tiansen Li · National Eye Institute · ZIA · FY2016 · EY
Development of an M1 PAM experimental therapeutic for schizophrenia
$2,072,400P Jeffrey Conn · Vanderbilt University · U19 · FY2015 · MH
Growth Factor Imaging and Photoimmunotherapy
$2,071,751Peter L. Choyke · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Novel Therapeutic Strategies in Human Myeloid Leukemias
$2,071,388Dana-Farber Cancer Institute · P01 · FY2003 · CA
Acquisition of a High-Field Dual Source FTICR-MS for Pharmaceutical Research
$2,070,000Lingjun Li · University Of Wisconsin-Madison · S10 · FY2011 · RR
Preclinical drug development in pancreatic cancer
$2,069,338Udo Rudloff · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Autophagy-Inducting Peptides and Target Identification for Treatment of Viruses
$2,068,997Beth C Levine · Washington University · U19 · FY2018 · AI
BIOLOGY OF OVARIAN CANCER
$2,068,795University Of California San Francisco · P01 · FY2001 · CA
1/1: ARREST RESPIRATORY FAILURE DUE TO PNEUMONIA (ARREST PNEUMONIA)
$2,068,764Joseph Eric Levitt · Stanford University · UH3 · FY2022 · HL
Natural Products Discovery and Characterization Through Network Collaborations
$2,068,646Kirk Gustafson · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
DCTD Natural Products Extraction
$2,068,252David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2012 · CA
Center for Protein Structure and Function
$2,068,071Francis S Millett · University Of Arkansas At Fayetteville · P20 · FY2006 · RR
RCMI Research Capacity Core
$2,067,369Vladimir Kolesnichenko · Xavier University Of Louisiana · U54 · FY2025 · MD
1/1: ARREST RESPIRATORY FAILURE DUE TO PNEUMONIA (ARREST PNEUMONIA)
$2,065,518Joseph Eric Levitt · Stanford University · UH3 · FY2020 · HL
Subcellular protein localization in B. subtilis
$2,065,516Kumaran Ramamurthi · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Understanding mechanisms and seeking novel biomarkers in Alzheimer's disease
$2,064,916Madhav Thambisetty · National Institute On Aging · ZIA · FY2021 · AG
1/1: ARREST RESPIRATORY FAILURE DUE TO PNEUMONIA (ARREST PNEUMONIA)
$2,064,826Joseph Eric Levitt · Stanford University · UH3 · FY2021 · HL
Cardiovascular Genomics and Bioinformatics projects
$2,064,651Andrew Johnson · National Heart, Lung, And Blood Institute · ZIA · FY2022 · HL
Mechanisms Of Drug-induced Toxicities
$2,064,257Lance R Pohl · Heart, Lung, And Blood Institute · Z01 · FY2007 · HL
Pharmacogenomic Evaluation of Antihypertensive Responses
$2,064,000Julie A. Johnson · University Of Florida · U01 · FY2010 · GM
Harvard-wide Program on Antibiotic Resistance
$2,061,148Michael S. Gilmore · Massachusetts Eye And Ear Infirmary · P01 · FY2016 · AI
Multivalent display of anthrax toxin inhibitors
$2,060,333Scripps Research Institute · P01 · FY2005 · AI
An Integrated Approach to Diversity-Oriented Synthesis
$2,059,985Stuart L Schreiber · Broad Institute, Inc. · P50 · FY2011 · GM
Immunologic And Virologic Approaches To HIV-1 Therapeutics
$2,059,757Richard Davey · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI